Free Trial
LON:DPH

Dechra Pharmaceuticals (DPH) Share Price, News & Analysis

Dechra Pharmaceuticals logo

About Dechra Pharmaceuticals Stock (LON:DPH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
3,866
3,866
52-Week Range
N/A
Volume
2.04 million shs
Average Volume
1.29 million shs
Market Capitalization
£4.40 billion
P/E Ratio
N/A
Dividend Yield
1.20%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dechra Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

DPH Stock News Headlines

Dechra Pharmaceuticals PLC (DPH.L)
I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
Form 8.3 - Dechra Phartmaceuticals PLC - Amendment
Dechra Pharmaceuticals PLC DPH
See More Headlines

DPH Stock Analysis - Frequently Asked Questions

Shares of DPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dechra Pharmaceuticals investors own include 32Red (TTR), 1428686 (SGP.L) (SGP), JD Sports Fashion (JD), Ashtead Group (AHT), Rolls-Royce Holdings plc (RR.L), Cranswick (CWK) and Drax Group (DRX).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
Personal Services
Current Symbol
LON:DPH
CIK
N/A
Fax
N/A
Employees
2,457
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.42
Net Income
-£27.90 million
Net Margins
-3.66%
Pretax Margin
N/A
Return on Equity
-3.92%
Return on Assets
0.75%

Debt

Debt-to-Equity Ratio
66.80
Current Ratio
2.85
Quick Ratio
1.66

Sales & Book Value

Annual Sales
£761.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
24.43
Book Value
GBX 663 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
113,910,000
Free Float
N/A
Market Cap
£4.40 billion
Optionable
Not Optionable
Beta
0.78
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:DPH) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners